Skip to main content
Top
Published in: Strahlentherapie und Onkologie 4/2016

01-04-2016 | Original Article

Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy

A prospective trial

Authors: Sebastià Sabater, MD.,PhD., Ignacio Andrés, Marina Gascon, Angeles Rovirosa, Marimar Sevillano, Roberto Berenguer, Cristina Camacho-Lopez, Manuel Aguayo, Maria Victoria Villas, Meritxell Arenas

Published in: Strahlentherapie und Onkologie | Issue 4/2016

Login to get access

Abstract

Purpose

To evaluate the effects of rectal enemas on rectal doses during postoperative high-dose-rate (HDR) vaginal cuff brachytherapy (VCB).

Patients and methods

This prospective trial included 59 patients. Two rectal cleansing enemas were self-administered before the second fraction, and fraction 1 was considered the basal status. Dose–volume histogram (DVH) values were generated for the rectum and correlated with rectal volume variation. Statistical analyses used paired and unpaired t-tests.

Results

Despite a significant 15 % reduction in mean rectal volume (44.07 vs. 52.15 cc, p = 0.0018), 35.6 % of patients had larger rectums after rectal enemas. No significant rectal enema-related DVH differences were observed compared to the basal data. Although not statistically significant, rectal cleansing-associated increases in mean rectal DVH values were observed: D0.1 cc: 6.6 vs. 7.21 Gy; D1 cc: 5.35 vs. 5.52 Gy; D2 cc: 4.67 vs. 4.72 Gy, before and after rectal cleaning, respectively (where Dx cc is the dose to the most exposed x cm3). No differences were observed in DVH parameters according to rectal volume increase or decrease after the enema. Patients whose rectal volume increased also had significantly larger DVH parameters, except for D5 %, D25 %, and D50 %. In contrast, in patients whose rectal volume decreased, significance was only seen for D25 % and D50 % (Dx % dose covering x % of the volume). In the latter patients, nonsignificant reductions in D2 cc, D5 cc and V5 Gy (volume receiving at least 5 Gy) were observed.

Conclusion

The current rectal enemas protocol was ineffective in significantly modifying rectal DVH parameters for HDR-VCB.
Literature
1.
go back to reference Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404–1411CrossRefPubMed Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404–1411CrossRefPubMed
2.
go back to reference Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751CrossRefPubMed Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751CrossRefPubMed
3.
go back to reference Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816–823CrossRefPubMed Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816–823CrossRefPubMed
4.
go back to reference Landoni F, Maneo A, Colombo A et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350:535–540CrossRefPubMed Landoni F, Maneo A, Colombo A et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet 350:535–540CrossRefPubMed
5.
go back to reference Neumann O, Kluge A, Lyubina O et al (2014) Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients. Strahlenther Onkol 190:538–545CrossRefPubMed Neumann O, Kluge A, Lyubina O et al (2014) Robotic radiosurgery as an alternative to brachytherapy for cervical cancer patients. Strahlenther Onkol 190:538–545CrossRefPubMed
6.
go back to reference Davila Fajardo R, van Os R, Buist MR et al (2014) Post-operative radiotherapy in patients with early stage cervical cancer. Gynecol Oncol 134:52–59CrossRefPubMed Davila Fajardo R, van Os R, Buist MR et al (2014) Post-operative radiotherapy in patients with early stage cervical cancer. Gynecol Oncol 134:52–59CrossRefPubMed
7.
go back to reference Rotman M, Sedlis A, Piedmonte MR et al (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65:169–176CrossRefPubMed Rotman M, Sedlis A, Piedmonte MR et al (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65:169–176CrossRefPubMed
8.
go back to reference Mazeron R, Gilmore J, Champoudry J et al (2014) Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer. Strahlenther Onkol 190:41–47CrossRefPubMed Mazeron R, Gilmore J, Champoudry J et al (2014) Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer. Strahlenther Onkol 190:41–47CrossRefPubMed
9.
go back to reference Potter R, Gerbaulet A, Haie-Meder C (2002) Endometrial cancer. The GEC ESTRO Handbook of Brachytherapy. ESTRO, Leuven, pp 365–401 Potter R, Gerbaulet A, Haie-Meder C (2002) Endometrial cancer. The GEC ESTRO Handbook of Brachytherapy. ESTRO, Leuven, pp 365–401
10.
go back to reference Small W, Beriwal S, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 11:58–67CrossRefPubMed Small W, Beriwal S, Demanes DJ et al (2012) American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 11:58–67CrossRefPubMed
12.
go back to reference Sabater S, Sevillano M, Andres I et al (2013) Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy. Strahlenther Onkol 189:951–956CrossRefPubMed Sabater S, Sevillano M, Andres I et al (2013) Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy. Strahlenther Onkol 189:951–956CrossRefPubMed
13.
go back to reference Deasy JO, Blanco AI, Clark VH (2003) CERR: a computational environment for radiotherapy research. Med Phys 30:979–985CrossRefPubMed Deasy JO, Blanco AI, Clark VH (2003) CERR: a computational environment for radiotherapy research. Med Phys 30:979–985CrossRefPubMed
14.
go back to reference About Epworth Radiation Oncology. Accessed 17 Feb 2015 About Epworth Radiation Oncology. Accessed 17 Feb 2015
15.
go back to reference Intracavitary implants (2015) Gynecologic brachytherapy. Accessed 17 Feb 2015 Intracavitary implants (2015) Gynecologic brachytherapy. Accessed 17 Feb 2015
16.
go back to reference Lim J, Durbin-Johnson B, Valicenti R et al (2013) The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer 23:1078–1083CrossRefPubMedPubMedCentral Lim J, Durbin-Johnson B, Valicenti R et al (2013) The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer 23:1078–1083CrossRefPubMedPubMedCentral
17.
go back to reference Iati G, Pontoriero A, Mondello S et al (2014) Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position. Brachytherapy 13:568–571CrossRefPubMed Iati G, Pontoriero A, Mondello S et al (2014) Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position. Brachytherapy 13:568–571CrossRefPubMed
18.
go back to reference Guler OC, Onal C, Acibuci I (2014) Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer. J Contemp Brachytherapy 6:371–376CrossRefPubMedPubMedCentral Guler OC, Onal C, Acibuci I (2014) Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer. J Contemp Brachytherapy 6:371–376CrossRefPubMedPubMedCentral
19.
go back to reference Hung J, Shen S, De Los Santos JF et al (2012) Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk. Int J Radiat Oncol Biol Phys 83:980–985CrossRefPubMed Hung J, Shen S, De Los Santos JF et al (2012) Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk. Int J Radiat Oncol Biol Phys 83:980–985CrossRefPubMed
20.
go back to reference Kim RY, Shen S, Lin HY et al (2010) Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 76:485–489CrossRefPubMed Kim RY, Shen S, Lin HY et al (2010) Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 76:485–489CrossRefPubMed
21.
go back to reference Stewart AJ, Cormack RA, Lee H et al (2008) Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys 72:843–848CrossRefPubMedPubMedCentral Stewart AJ, Cormack RA, Lee H et al (2008) Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy. Int J Radiat Oncol Biol Phys 72:843–848CrossRefPubMedPubMedCentral
22.
go back to reference Hoskin PJ, Bownes P, Summers A (2002) The influence of applicator angle on dosimetry in vaginal vault brachytherapy. Br J Radiol 75:234–237CrossRefPubMed Hoskin PJ, Bownes P, Summers A (2002) The influence of applicator angle on dosimetry in vaginal vault brachytherapy. Br J Radiol 75:234–237CrossRefPubMed
23.
go back to reference Holloway CL, Macklin EA, Cormack RA et al (2011) Should the organs at risk be contoured in vaginal cuff brachytherapy? Brachytherapy 10:313–317CrossRefPubMed Holloway CL, Macklin EA, Cormack RA et al (2011) Should the organs at risk be contoured in vaginal cuff brachytherapy? Brachytherapy 10:313–317CrossRefPubMed
24.
go back to reference Sabater S, Andres I, Sevillano M et al (2013) Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition. Brachytherapy 13:343–351CrossRefPubMed Sabater S, Andres I, Sevillano M et al (2013) Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition. Brachytherapy 13:343–351CrossRefPubMed
25.
go back to reference Longo JM, Chen S, Thompson R et al (2011) Measuring the interfractional variation in dose to the rectum and the bladder using CT-based treatment planning for postoperative high dose rate vaginal brachytherapy in women with endometrial cancer. Int J Radiat Oncol Biol Phys 81:S478CrossRef Longo JM, Chen S, Thompson R et al (2011) Measuring the interfractional variation in dose to the rectum and the bladder using CT-based treatment planning for postoperative high dose rate vaginal brachytherapy in women with endometrial cancer. Int J Radiat Oncol Biol Phys 81:S478CrossRef
26.
go back to reference Rovirosa A, Valduvieco I, Ascaso C et al (2013) Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma. Clin Transl Oncol 15:111–116CrossRefPubMed Rovirosa A, Valduvieco I, Ascaso C et al (2013) Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma. Clin Transl Oncol 15:111–116CrossRefPubMed
27.
go back to reference Valduvieco I, Rovirosa A, Herreros A et al (2012) Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity. Clin Transl Oncol. doi:10.1007/s12094-012-0974-0 Valduvieco I, Rovirosa A, Herreros A et al (2012) Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity. Clin Transl Oncol. doi:10.1007/s12094-012-0974-0
Metadata
Title
Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy
A prospective trial
Authors
Sebastià Sabater, MD.,PhD.
Ignacio Andrés
Marina Gascon
Angeles Rovirosa
Marimar Sevillano
Roberto Berenguer
Cristina Camacho-Lopez
Manuel Aguayo
Maria Victoria Villas
Meritxell Arenas
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 4/2016
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-016-0940-9

Other articles of this Issue 4/2016

Strahlentherapie und Onkologie 4/2016 Go to the issue